A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre-Reference-Cited by-同舟云学术

A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre

Published:2021-08-17 Issue:5 Volume:8 Page:3720-3725
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Kennel Peter J.¹^ORCID,Lumish Heidi¹,Kaku Yuji²,Fried Justin¹,Kirtane Ajay J.¹³,Karmpaliotis Dimitri¹,Takayama Hiroo²,Naka Yoshifumi²,Sayer Gabriel¹,Uriel Nir¹,Takeda Koji²,Masoumi Amirali¹

Affiliation:

1. Division of Cardiology Columbia University Irving Medical Center/NewYork‐Presbyterian Hospital 161 Fort Washington Avenue New York NY 10032 USA

2. Division of Cardiothoracic Surgery NewYork‐Presbyterian Hospital New York NY USA

3. Division of Cardiology Cardiovascular Research Foundation New York NY USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13512

Reference17 articles.

1. First U.S. Patients Treated with Impella 5.5 with SmartAssist a Minimally Invasive Forward Flow Heart Pump|ABIOMED Inc.https://investors.abiomed.com/news‐releases/news‐release‐details/first‐us‐patients‐treated‐impella‐55‐smartassist‐minimally(accessed date: 11 March 2021)

2. New Surgical Circulatory Support System Outcomes

3. Impella 5.5 Versus Centrimag: A Head-to-Head Comparison of Device Hemocompatibility

4. Switching to Impella 5.0 decreases need for transfusion in patients undergoing temporary mechanical circulatory support

5. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impella 5.5: A Systematic Review of the Current Literature;Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery;2024-09-12

2. Brief Version of Chinese Society of Cardiology Guidelines on the Diagnosis and Treatment of Adult Fulminant Myocarditis;International Journal of Drug Discovery and Pharmacology;2024-08-20

3. Prolonged Impella 5.0/5.5 support within different pathways of care for cardiogenic shock: the experience of a referral center;Frontiers in Cardiovascular Medicine;2024-07-02

4. Patient Characteristics and Early Clinical Outcomes With Impella 5.5: A Systematic Review and Meta-Analysis;ASAIO Journal;2024-02-22

5. Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis;Science China Life Sciences;2024-02-07